☆ 4.7 Article

Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Erik Volz et al.

Summary: The study suggests a positive selection for the SARS-CoV-2 spike protein variant D614G in the UK, but no evidence of differences in COVID-19 mortality or clinical severity in patients infected with this variant. 614G is associated with higher viral load and younger age of patients compared to 614D.

CELL (2021)

添加到收藏夹

Article Immunology

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

Vincent Legros et al.

Summary: The study investigated the neutralizing antibody response in serum samples from 140 confirmed SARS-CoV-2 infections, finding that antibody titers correlated with disease severity and anti-spike IgG levels. Post-recovery, patients' nAb activity declined more rapidly compared to individuals infected with other coronaviruses, and previous infection by human coronaviruses did not generate protective nAbs against SARS-CoV-2. Additionally, the D614G mutation in the spike protein did not lead to neutralization escape.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

M. J. Joyner et al.

Summary: This study found that higher anti-SARS-CoV-2 IgG antibody levels in convalescent plasma were associated with a lower risk of death among patients hospitalized with Covid-19 who were not receiving mechanical ventilation. The association between antibody levels and mortality risk was moderated by mechanical ventilation status, with no significant effect seen in patients who had already received ventilation.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.

CELL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang et al.

Summary: Volunteers who received the Moderna or Pfizer-BioNTech vaccine showed high levels of antibodies and memory B cell responses against SARS-CoV-2, with activity similar to individuals who had recovered from natural infection. However, their efficacy against specific SARS-CoV-2 variants was reduced, indicating a potential need for periodic updates to mRNA vaccines to maintain clinical efficacy.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma

For Yue Tso et al.

Summary: Specific IgG antibodies against SARS-CoV-2 were detected in all COVID-19 subjects, with most of them also showing high neutralizing potency and strong ADCC activity. These findings suggest that protection against SARS-CoV-2 may not only rely on neutralizing antibodies but also on ADCC mediated by both neutralizing and non-neutralizing antibodies.

PLOS ONE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Adam K. Wheatley et al.

Summary: The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection and vaccine development. Antibody, B cell, and T cell responses decline over the first 4 months post-infection, while S-specific IgG(+) memory B cells consistently accumulate. The study suggests that natural infection may only provide transient protection at a population level, highlighting the need for more immunogenic and durable vaccines.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Immunology

Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection

Lin Yao et al.

Summary: This study investigated the humoral and T and B cell responses in COVID-19 patients up to 343 days after infection. It found that most patients still had virus-specific immune memory responses approximately 1 year post-infection, which is promising for prevention from reinfection and vaccination strategies.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Delayed production of neutralizing antibodies correlates with fatal COVID-19

Carolina Lucas et al.

Summary: Recent studies have shown that COVID-19 mortality is not primarily correlated with antiviral antibody levels, but more with the slower kinetics of antibody production.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications

Salim S. Abdool Karim et al.

Summary: The emergence of SARS-CoV-2 variants, including B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351), and P.1 (B.1.1.28.1), has raised concerns about worsening Covid-19 and potential escape from vaccine-induced immunity.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

The first Chinese national standards for SARS-CoV-2 neutralizing antibody

Lidong Guan et al.

Summary: By establishing and approving the first Chinese National Standard for SARS-CoV-2 neutralizing antibody, the quality and efficacy assessment of COVID-19 vaccines and therapeutics in China has been standardized and improved.

VACCINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri et al.

Summary: The study reveals that antibody responses to SARS-CoV-2 spike protein play a significant role in neutralization and protection against severe COVID-19, unaffected by heterologous boosting or common cold immunity, and can last for up to 8 months.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Microbiology

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

Alexandra Tauzin et al.

Summary: A single dose of the BNT162b2 mRNA vaccine can be up to 90% effective, with boosted humoral and T cell responses in previously infected individuals. Therefore, spacing doses may help vaccinate more people in conditions of limited vaccine supply.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Immunology

Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection

Valeria De Giorgi et al.

Summary: This study conducted a longitudinal analysis of COVID-19 convalescent plasma donors over an 11-month period, finding that most individuals maintained detectable levels of anti-SARS-CoV-2 IgG and neutralizing titers up to 11 months after symptom recovery. However, some donors experienced a decline in neutralization levels to undetectable titers over time.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Broad betacoronavirus neutralization by a stem helix-specific human antibody

Dora Pinto et al.

Summary: The study identified five monoclonal antibodies from COVID-19 convalescent individuals that cross-react with multiple betacoronavirus spike glycoproteins, with one antibody (S2P6) showing broad neutralization of viruses from three different subgenera. This antibody reduced viral burden in hamsters challenged with SARS-CoV-2 by inhibiting membrane fusion, providing a framework for the design of pan-betacoronavirus vaccines for broad protection.

SCIENCE (2021)

添加到收藏夹

Article Virology

The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein

Xuemin Chen et al.

Summary: The study demonstrated that ADCC assay can accurately identify antibody responses to SARS-CoV-2 in convalescent patients, but not in healthy controls. There was a slight decline in ADCC titer over time, primarily mediated through the NK Fc gamma RIIIa receptor for cell lysis. The assay showed high sensitivity and specificity for detecting immune responses to SARS-CoV-2.

VIROLOGY (2021)

添加到收藏夹

Article Cell Biology

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

Sai Priya Anand et al.

Summary: Recent research on convalescent individuals of COVID-19 has shown a decline in antibody levels in plasma, while specific memory B cells remain present. IgM antibodies against Spike and RBD decay rapidly, whereas IgG decline is less significant. Understanding these immune memory responses is crucial for secondary infection prevention and vaccine efficacy.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Cell Biology

Decay of Fc-dependent antibody functions after mild to moderate COVID-19

Wen Shi Lee et al.

Summary: During the convalescence from COVID-19, the Fc-dependent functions of SARS-CoV-2 spike-specific antibodies decrease over time. Despite a significant decline in antibody-dependent cellular cytotoxicity and antibody-dependent phagocytosis activity, they remain detectable in most subjects.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Cell Biology

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies

Jeremy Dufloo et al.

Summary: Asymptomatic individuals infected with SARS-CoV-2 have lower levels of antibody response, but are still able to neutralize the virus and target infected cells. There are differences in antibody levels and functions between asymptomatic individuals and symptomatic cases, but antibody functions are correlated regardless of disease severity. Longitudinal samplings show that antibody functions follow similar kinetics of induction and contraction.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Immunology

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Katharine H. D. Crawford et al.

Summary: Antibody levels, including neutralizing antibodies, decline after SARS-CoV-2 infection, with a 4-fold average decrease in titers from 1 to 4 months after symptom onset. This decline is accompanied by a decrease in total antibodies capable of binding the viral spike protein. Further studies are needed to determine the long-term durability of immunity to SARS-CoV-2, including examination of long-lived B cells and antibody titers over extended periods.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Cell Biology

The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens

Hillary A. Vanderven et al.

IMMUNOLOGY AND CELL BIOLOGY (2020)

添加到收藏夹

Article Microbiology

Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies

Thach H. Chu et al.

PLOS PATHOGENS (2020)

添加到收藏夹

Article Immunology

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers et al.

SCIENCE (2020)

添加到收藏夹

Article Microbiology

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate

Amin Addetia et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

添加到收藏夹

Article Immunology

The Presence of Antibody-Dependent Cell Cytotoxicity-Mediating Antibodies in Kaposi Sarcoma-Associated Herpesvirus-Seropositive Individuals Does Not Correlate with Disease Pathogenesis or Progression

Lisa K. Poppe et al.

JOURNAL OF IMMUNOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Sean T. H. Liu et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters

Alina Baum et al.

SCIENCE (2020)

添加到收藏夹

Review Multidisciplinary Sciences

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Angkana T. Huang et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Microbiology

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Jeffrey Seow et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection

Wei Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Immunology

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Jianhui Nie et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Review Immunology

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization

Bin Su et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Microbiology

A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus

Bronwyn M. Gunn et al.

CELL HOST & MICROBE (2018)

添加到收藏夹

Review Immunology

Effect of Natural Compounds on NK Cell Activation

Malgorzata Grudzien et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

添加到收藏夹

Review Immunology

Beyond binding: antibody effector functions in infectious diseases

Lenette L. Lu et al.

NATURE REVIEWS IMMUNOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody-dependent-cellular-cytotoxicity- inducing antibodies significantly affect the post-LEexposure treatment of Ebola virus infection

Qiang Liu et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Virology

Antibody-dependent cellular cytotoxicity and influenza virus

Hillary A. Vanderven et al.

CURRENT OPINION IN VIROLOGY (2017)

添加到收藏夹

Article Immunology

High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children

Masanori Terajima et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

添加到收藏夹

Article Multidisciplinary Sciences

A broadly neutralizing human monoclonal antibody is effective against H7N9

Kannan Tharakaraman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

添加到收藏夹

Article Medicine, Research & Experimental

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

Shuying S. Li et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

添加到收藏夹

Article Immunology

Relationship of Preexisting Influenza Hemagglutination Inhibition, Complement-Dependent Lytic, and Antibody-Dependent Cellular Cytotoxicity Antibodies to the Development of Clinical Illness in a Prospective Study of A(H1N1)pdm09 Influenza in Children

Mary Dawn T. Co et al.

VIRAL IMMUNOLOGY (2014)

添加到收藏夹

Article Cell Biology

Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease

Surender Khurana et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

添加到收藏夹

Article Immunology

Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: Potential involvement in early control of viral replication

Kamolwish Laoprasopwattana et al.

JOURNAL OF INFECTIOUS DISEASES (2007)

添加到收藏夹

Article Immunology

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

VC Huber et al.

JOURNAL OF IMMUNOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.